Lysergic acid hydroxyethylamide

From WikiMD's WELLNESSPEDIA

Lysergic acid hydroxyethylamide (also known as LAH) is a derivative of lysergic acid. It is a member of the lysergamide family and has a similar structure to LSD.

Etymology[edit]

The name "Lysergic acid hydroxyethylamide" is derived from its chemical structure. "Lysergic acid" refers to the base compound, while "hydroxyethylamide" refers to the functional groups attached to the base compound.

Chemistry[edit]

Lysergic acid hydroxyethylamide is a derivative of lysergic acid, which is itself derived from the ergot fungus. It is a member of the lysergamide family, which also includes substances such as LSD, ALD-52, and 1P-LSD. Like other lysergamides, LAH is believed to act as a serotonin receptor agonist.

Pharmacology[edit]

The pharmacology of lysergic acid hydroxyethylamide is not well-studied. However, due to its structural similarity to other lysergamides, it is believed to act primarily as a serotonin receptor agonist. This means it binds to and activates the serotonin receptors in the brain, which are involved in mood, cognition, and perception.

Effects[edit]

The effects of lysergic acid hydroxyethylamide are not well-documented, as it is not commonly used recreationally or medically. However, based on its structural similarity to other lysergamides, it is likely to produce effects similar to those of LSD, including altered perception, hallucinations, and changes in thought processes.

Legal Status[edit]

The legal status of lysergic acid hydroxyethylamide varies by country. In many countries, it is considered a controlled substance due to its similarity to LSD.

See Also[edit]


Lysergic acid hydroxyethylamide[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.